Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

A Common Rule for Resection of Glioblastoma in the Molecular Era.

Choi BD, Gerstner ER, Curry WT Jr.

JAMA Oncol. 2020 Feb 6. doi: 10.1001/jamaoncol.2019.6384. [Epub ahead of print] No abstract available.

PMID:
32027348
2.

Survival Benefit of Maximal Resection for Glioblastoma Reoperation in the Temozolomide Era: A Meta-Analysis.

Lu VM, Goyal A, Graffeo CS, Perry A, Burns TC, Parney IF, Quinones-Hinojosa A, Chaichana KL.

World Neurosurg. 2019 Jul;127:31-37. doi: 10.1016/j.wneu.2019.03.250. Epub 2019 Apr 1. Review.

PMID:
30947000
3.

Odds of death after glioblastoma diagnosis in the United States by chemotherapeutic era.

Wachtel MS, Yang S.

Cancer Med. 2014 Jun;3(3):660-6. doi: 10.1002/cam4.213. Epub 2014 Mar 10.

4.

Prognostic Value of Tumor Volume in Glioblastoma Patients: Size Also Matters for Patients with Incomplete Resection.

Bette S, Barz M, Wiestler B, Huber T, Gerhardt J, Buchmann N, Combs SE, Schmidt-Graf F, Delbridge C, Zimmer C, Kirschke JS, Meyer B, Ryang YM, Ringel F, Gempt J.

Ann Surg Oncol. 2018 Feb;25(2):558-564. doi: 10.1245/s10434-017-6253-0. Epub 2017 Nov 20. Erratum in: Ann Surg Oncol. 2018 Mar 19;:.

PMID:
29159745
5.

Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy.

Kreth FW, Thon N, Simon M, Westphal M, Schackert G, Nikkhah G, Hentschel B, Reifenberger G, Pietsch T, Weller M, Tonn JC; German Glioma Network.

Ann Oncol. 2013 Dec;24(12):3117-23. doi: 10.1093/annonc/mdt388. Epub 2013 Oct 14.

6.

Survival Trends in Elderly Patients with Glioblastoma in the United States: a Population-based Study.

Shah BK, Bista A, Sharma S.

Anticancer Res. 2016 Sep;36(9):4883-6.

PMID:
27630344
7.

Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era.

Ortega A, Sarmiento JM, Ly D, Nuño M, Mukherjee D, Black KL, Patil CG.

J Clin Neurosci. 2016 Feb;24:105-11. doi: 10.1016/j.jocn.2015.05.047. Epub 2015 Dec 5.

PMID:
26671314
8.

[The sodium fluorescein-guided microsurgical resection of glioblastoma].

Hong J, Chen BD, Yao X, Yang YS.

Zhonghua Wai Ke Za Zhi. 2018 Aug 1;56(8):611-616. doi: 10.3760/cma.j.issn.0529-5815.2018.08.012. Chinese.

PMID:
30107705
9.

Safety and outcomes of resection of butterfly glioblastoma.

Dayani F, Young JS, Bonte A, Chang EF, Theodosopoulos P, McDermott MW, Berger MS, Aghi MK.

Neurosurg Focus. 2018 Jun;44(6):E4. doi: 10.3171/2018.3.FOCUS1857.

PMID:
29852771
10.

A Comparative Analysis of the Usefulness of Survival Prediction Models for Patients with Glioblastoma in the Temozolomide Era: The Importance of Methylguanine Methyltransferase Promoter Methylation, Extent of Resection, and Subventricular Zone Location.

Woo P, Ho J, Lam S, Ma E, Chan D, Wong WK, Mak C, Lee M, Wong ST, Chan KY, Poon WS.

World Neurosurg. 2018 Jul;115:e375-e385. doi: 10.1016/j.wneu.2018.04.059. Epub 2018 Apr 17.

PMID:
29678708
11.

Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.

Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, Parney IF.

J Neurosurg. 2013 Apr;118(4):786-98. doi: 10.3171/2012.10.JNS112268. Epub 2012 Nov 23.

PMID:
23176331
12.

Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival.

Pollom EL, Fujimoto DK, Han SS, Harris JP, Tharin SA, Soltys SG.

J Radiat Res. 2018 Mar 1;59(suppl_1):i11-i18. doi: 10.1093/jrr/rrx103.

13.

A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.

Konar SK, Bir SC, Maiti TK, Nanda A.

J Neurosurg Pediatr. 2017 Feb;19(2):239-248. doi: 10.3171/2016.8.PEDS1631. Epub 2016 Nov 4. Review.

PMID:
27813458
14.

Prognosis of patients with multifocal glioblastoma: a case-control study.

Patil CG, Yi A, Elramsisy A, Hu J, Mukherjee D, Irvin DK, Yu JS, Bannykh SI, Black KL, Nuño M.

J Neurosurg. 2012 Oct;117(4):705-11. doi: 10.3171/2012.7.JNS12147. Epub 2012 Aug 24.

PMID:
22920963
15.

Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group.

Buglione M, Borghetti P, Pedretti S, Triggiani L, Fontanella MM, Spena G, Grisanti S, Liserre R, Poliani LP, Gipponi S, Spiazzi L, Magrini SM.

Radiol Med. 2015 Oct;120(10):975-81. doi: 10.1007/s11547-015-0528-y. Epub 2015 Mar 15.

PMID:
25773653
16.

Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme.

Höhne J, Schebesch KM, de Laurentis C, Akçakaya MO, Pedersen CB, Brawanski A, Poulsen FR, Kiris T, Cavallo C, Broggi M, Ferroli P, Acerbi F.

World Neurosurg. 2019 May;125:e158-e164. doi: 10.1016/j.wneu.2019.01.024. Epub 2019 Jan 22.

PMID:
30682505
17.

The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

Li YM, Suki D, Hess K, Sawaya R.

J Neurosurg. 2016 Apr;124(4):977-88. doi: 10.3171/2015.5.JNS142087. Epub 2015 Oct 23.

PMID:
26495941
18.

Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.

Hoffermann M, Bruckmann L, Kariem Mahdy A, Asslaber M, Payer F, von Campe G.

Clin Neurol Neurosurg. 2015 Jan;128:60-9. doi: 10.1016/j.clineuro.2014.11.006. Epub 2014 Nov 15.

PMID:
25462098
19.

Preoperative prognostic neurologic index for glioblastoma patients receiving tumor resection.

Liang HK, Wang CW, Tseng HM, Huang CY, Lan KH, Chen YH, You SL, Cheng JC, Cheng AL, Kuo SH.

Ann Surg Oncol. 2014 Nov;21(12):3992-8. doi: 10.1245/s10434-014-3793-4. Epub 2014 May 23.

PMID:
24854491
20.

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

Bell EH, Pugh SL, McElroy JP, Gilbert MR, Mehta M, Klimowicz AC, Magliocco A, Bredel M, Robe P, Grosu AL, Stupp R, Curran W Jr, Becker AP, Salavaggione AL, Barnholtz-Sloan JS, Aldape K, Blumenthal DT, Brown PD, Glass J, Souhami L, Lee RJ, Brachman D, Flickinger J, Won M, Chakravarti A.

JAMA Oncol. 2017 Jun 1;3(6):784-792. doi: 10.1001/jamaoncol.2016.6020.

Supplemental Content

Support Center